Benznidazole and Nifurtimox (Repurposed Drugs)

Type: drug

Status: FDA Approved (for pediatric Chagas, Benznidazole)

Developer: Roche (Benznidazole), Bayer (Nifurtimox)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026